Physiological, pharmacological and genetic studies in dogs, mice and rats have established that the uncoupling protein-1 (UCP1)-based brown adipose tissue system has an important role in the regulation of body temperature. Although it may be possible to create laboratory conditions in which mice with inactivated Ucp1 can survive in a modestly cooled environment, data overwhelmingly support the conclusion that the UCP1/BAT system has evolved to maintain body temperature at 37 1C. The corollary to this conclusion is that any influence UCP1/BAT might have on body weight regulation is a secondary function. The idea that BAT prevents obesity by burning off excess energy to maintain energy balance seems incompatible with evolutionary biology. Premodern humans spent an enormous amount of energy either running to catch their meal or avoiding becoming a meal themselves; consequently, there was no obesity. Nevertheless, although secondary to body temperature regulation, UCP1/BAT is extraordinarily effective at reducing adiposity and insulin resistance in mice and rats. Variation among mice in susceptibility to diet-induced obesity is correlated with the induction of brown adipocytes in traditional white fat depots (wBAT). Both genetic and cell biology-based experimentation have shown that the cellular origins of wBAT are different from those of interscapular-like brown adipocytes (iBAT). Do they have different functions? We have analyzed the effects of the early nutritional environment on the induction of brown adipocytes in inguinal fat to test the hypothesis that wBAT is primarily involved in body weight regulation. Although undernutrition during lactation severely suppresses wBAT at 21 days of age, undernourished mice fed a normal chow diet ad libitum at weaning recovered their normal wBAT and iBAT systems as young adults. The function of wBAT does not seem to be uniquely devoted to body weight regulation.
Introduction
The recent, although belated and overdue, realization by human biologists that brown adipose tissue exists in humans has renewed interest to explore how this remarkable thermogenic system can be applied to the problem of human obesity. [1] [2] [3] This is not the first time that brown fat has been courted as a panacea for the obesity problem. At the end of the 1970s, the coincidence of the Rothwell and Stock paper linking diet-induced thermogenesis to brown fat in rats, with evidence that cold sensitivity and obesity phenotypes in ob/ob mice was associated with defective energy expenditure and brown adipose tissue nonshivering thermogenesis, set in motion efforts by clinicians to find obese individuals with a slow metabolism and defective brown fat. [4] [5] [6] Prentice has commented on the depth and frustration experienced by clinicians when they failed to find obese humans with slow metabolism. 7 In fact, obese humans have increased energy expenditure. 8 Prentice blamed the ob/ob mouse for this fruitless phase of obesity research in humans, believing that the fundamental phenotypes of obesity and body weight regulation in ob/ob mice and humans were different. We now know, after the discovery of humans with an inactive leptin gene, that the phenotypes of these humans and ob/ob mice are remarkably similar. 9 We have also discovered in the interim that ob/ob mice have neither reduced energy expenditure nor defective brown fat per se, although signaling from the hypothalamus to the brown fat may be attenuated. 10, 11 It was not the mouse genetic models that led the clinicians astray; rather, those studying energy expenditure in obese mice did not know how to calculate energy expenditure, a problem that persists with frustrating frequency to this day. 12 Given this history of brown fat thermogenesis and human obesity, it is appropriate at this time to review phenotypes and characteristics of brown adipose tissue in experimental rodents to determine which ones can be applied to human studies.
The phenotypes that I would like to review in this presentation are the following:
1. Genetic evidence that origins of brown adipocytes in white fat depots are distinct from those in discrete interscapular depots. 2. The ability of obese mice to reduce adiposity when exposed to the cold depends on the variation in the number of brown adipocytes in white fat depots, and not in discrete interscapular fat depots. 3. The complex synergistic nature of cell signaling and transcriptional regulation controlling induction of brown adipocyte in white fat depots, as revealed by quantitative trait locus analysis of the genetic variation in brown fat induction found among inbred strains of mice. 4. Microarray analysis of gene expression of the developing fat depot during postnatal development indicates that undernutrition during lactation strongly suppresses the induction of brown adipocytes in the inguinal fat at weaning. However, this suppression was transient, as there were no long-lasting effects on the induction of brown adipocytes in inguinal fat of adult mice, nor on adiposity. 5. Ectopic expression of Ucp1 can lead to an increase in energy expenditure, reduced adiposity and insulin resistance, but excessive UCP1 and other uncoupling proteins can lead to cell death of muscle cells and even of brown adipocytes.
Diffuse brown adipocytes in white fat depots
The appearance of inducible brown adipcoytes in traditional white fat depots (wBAT) following exposure to a low ambient temperature or treatment with a b3-adrenergic agonist was first described about 25 years ago. 13, 14 Studies followed establishing that these brown adipocytes were present in several mammalian species and that their induction/ presence was associated with reductions in both genetic and diet-induced adiposity. [15] [16] [17] [18] [19] Accordingly, the hypothesis emerged that wBAT has a unique physiological/thermogenic function associated with the regulation of body adiposity, whereas the function of interscapular brown adipose tissue lies in the protection of body temperature. To test this hypothesis rigorously, it is necessary to independently vary interscapular-like brown adipocytes (iBAT) and wBAT. Although it is possible to vary wBAT with iBAT being held invariant, there is currently no genetic model in which iBAT varies independently of wBAT. However, variation of wBAT without a corresponding variation in iBAT occurs in inbred strains of mice with spontaneous variant alleles, 20, 21 in transgenic mice in which inactivation of raptor in adipocytes by Febp4-Cre recombinase (aP2-Cre) leads to induction of brown adipocytes in white fat depots, without an effect on iBAT; similarly, inactivation of the gene encoding the vitamin D receptor leads to a strong induction of uncoupling protein-1 (Ucp1) in white fat depots. 22, 23 These models have provided strong evidence that mice with an elevated expression of wBAT are resistant to diet-induced obesity. Given the specificity of myf5 and PR-domain containing-16 (PRDM16) in determining the iBAT lineage, it is possible that variation in iBAT could be achieved independent of wBAT by manipulation of these genes. 24 Although PRDM16À/À mice are not viable, 24 it is possible that heterozygous PRDM16 þ /À mice have an iBAT phenotype, just as mice homozygous for inactivated raptorÀ/À are embryonic lethals; however, wBAT is induced in heterozygotes. It may be assumed from the few studies of Ucp1 expression in human white fat depots that this reflects the presence of diffusible brown adipocytes in white fat depots. However, morphological evidence showing mosaic patterns of brown adipocytes intermingled with white adipocytes has not been shown, nor do we know whether brown adipocytes are inducible in humans. The positron emission tomography images published to date show discrete areas in the subscapular regions and along the spinal cord. Although cold exposure will stimulate glucose uptake, and presumably thermogenesis, it is not known whether cold exposure will stimulate a proliferative response or a conversion of white to brown adipocytes as observed in mice.
Development of iBAT and wBAT
When we found that genetic variation in the induction of brown adipocytes in the retroperitoneal fat depot was not shared by iBAT, 20 we asked whether this reflected the timing of induction, that is, the stage of development when the stimulus signal was given. We tested this by analyzing for differences in expression between A/J and B6 mice during the early stages of brown fat differentiation in the fetus. 21 No genetic differences in any aspect of iBAT were observed for gene expression or morphology. Brown fat thermogenesis, which is fully differentiated at birth, is essential for survival of mice at birth when they have neither fur nor white adipose tissue. Whether it is required for the survival of humans is unknown. Pigs survive early development without an active UCP1 gene; therefore, an alternative thermogenic system must exist in these animals or sufficient heat may be produced/sustained by the size of the piglet, by high body fat content and by large litters, or possibly heat is generated by alternative thermogenic mechanisms, for example, the glycerol phosphate cycle, which is very highly expressed in brown adipocytes. A rapidly activated thermogenic system must be essential for most mammals to survive; even the pig in which the Ucp1 gene has been inactivated for 20 million years is cold sensitive, but has devised alternative strategies to survive. 25 Therefore, the frequency of fixation of random mutations to brown fat that affect expression levels in newborn animals are expected to be low. In contrast to iBAT, wBAT begins to emerge in developing white fat depots, both visceral and subcutaneous at approximately 10 days of age; it reaches a maximum at 21 days of age (weaning) and then regresses until it is scarcely detectable in 2-month-old mice. 21 Given the fact that the mouse is already growing fur at 10 days of age and has laid down a layer of fat, the danger from the cold has been substantially diminished. The function of wBAT, arriving late developmentally and remaining only transiently, predicts that if genetic mutations that caused variable expression occurred, it is unlikely to significantly affect survival from cold exposure and therefore more likely to be tolerated. There is insufficient information on BAT in humans to address these issues. Few morphological or biochemical studies have described brown adipocytes in babies. 26 wBAT and the regulation of adiposity
The induction of wBAT in normal adult mice occurs in response to cold exposure or stimulation by adrenergic agonists, and mice so induced will resist diet-induced obesity in proportion to the number of brown adipocytes following induction. This quantitative inductive response in wBAT is a genetically variable trait. 27 It can be argued that, as iBAT is not a genetically variable quantitative trait, it is not a determinant of the variation in obesity. These studies, together with others, particularly that with raptor, lead one to conclude that the primary function of wBAT is to burn off fat to protect the animal from developing a positive energy balance and insulin resistance. If the function of wBAT is to stimulate diet-induced thermogenesis, one would predict that wBAT and Ucp1 would be induced by a high-fat diet; however, the data on induction of Ucp1 gene expression by a high-fat diet are ambiguous, as is the induction of thermogenesis by a high-fat diet. Extensive analysis of Ucp1 induction in several hundred B6-A/J backcross mice in the presence and absence of a high-fat diet failed to show a significant effect of the high-fat diet on levels of Ucp1 mRNA in retroperitoneal fat. 20 On the other hand, with raptor þ /À and vitamin D receptorÀ/À mice, a high-fat diet led to increased Ucp1 in white fat depots and reduced adiposity. Paradoxically, Ucp1À/À mice fed a high-fat diet under standard ambient temperature in mouse rooms also had reduced adiposity compared with wild-type mice, although this difference was not observed at 28 1C. Thus, different mutants, some increasing Ucp1 and others eliminating UCP1, have the same tendency to reduce adiposity to levels normally seen in wild-type mice on a chow diet. 28 As adiposity of mutant mice and wild-type mice on a low-fat chow diet is frequently not different, it suggests that there is a physiological adaptation to maintain a lean body mass whether UCP1 is present or absent. Obviously, this mechanism, whatever it is, is strongly influenced by the ambient temperature because of the huge reduction in body fat when mice are housed in the cold; however, even under these cold conditions, the mouse will not be wasted, but will maintain a healthy body composition (5-19% fat) by increasing food intake by as much as 50% to satisfy the need to protect body temperature, as well as to maintain a minimal lean to fat mass composition. It has been argued that the phenotype in which UCP1-deficient mice do not become obese at standard temperatures in the animal rooms diminishes the value of UCP1/BAT thermogenesis as an antiobesity target for drug development; that is, if the animal becomes obese in the absence of UCP1, then a drug that enhances UCP1 thermogenesis becomes a rational antiobesity strategy. 29 The alternative point of view is that enhanced thermogenesis at reduced ambient temperatures between 20 and 23 1C, whether UCP1 is present or not, increases fat oxidation and reduces obesity.
If an ambient temperature of 20-23 1C is not tolerable to a modern human, then a b-adrenergic agonist may also work, if the side effects are more tolerable. A simple public policy advocating a reduction in the ambient temperature of home, schools and work place to a level sufficient to activate thermogenesis, whether based on UCP1 or alternative forms of thermogenesis, may have a very significant impact on reducing obesity without the inevitable side effects of a drug strategy.
Synergy among transcription and cell signaling pathways and the induction of wBAT
A 200-fold difference in Ucp1 mRNA levels among B6-and A/J-derived recombinant inbred strains of mice suggested that a quantitative trait locus (QTL) study (Ucp1 mRNA levels being the quantitative trait) would identify genes that control the induction of Ucp1 mRNA in response to cold exposure.
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When high-throughput real-time RT-PCR technology became available, we incorporated into the study the analysis of mRNA for transcription factors shown to be involved by Ucp1 expression by in vitro transient expression assays. 30 These genetic studies illustrated that the capacity of a mouse to induce wBAT did not depend on a single gene, rather eight or more genes were involved in various combinations to control the levels of Ucp1, peroxisome proliferator-activated receptor gamma coactivator 1a (Pgc-1a), peroxisome proliferator-activated receptor a (PPARa) and type 2 deiodinase. Not all genetic loci affect expression of Ucp1 and these regulatory factors; some QTLs were associated with PGC-1a expression and others with PPARa; only one QTL was involved with regulating Ucp1, PGC-1a, PPARa and Dio2. These gene interactions also changed in the presence or absence of a high-fat diet, even though the Ucp1 mRNA levels were not affected by the diet. 20 It may be that the changes associated with a high-fat diet have no significant biological impact on the thermogenic capacity of wBAT. Similar findings were associated with changes in the phosphorylated state of signaling molecules.
A model for the regulation of UCP1 in wBAT emerged of redundancy, synergy and plasticity. 30 Thus, we find that, despite the strong correlations between UCP1 and PPARa and PGC-1a mRNA levels in backcross mice, mice with an inactivated PPARa gene have levels of inducible Ucp1 in retroperitoneal fat that are indistinguishable from those of wild-type mice and from normal levels of Ucp1 in iBAT. 30, 31 Similarly, although the measurements have not been made, because mice with an inactivated PGC-1a have normal levels of Ucp1 iBAT, 32 it is highly probable that inducible Ucp1 in white fat depots is also normal in PGC-1a KO mice. Furthermore, despite evidence linking the b-1 and -3 adrenergic receptors to regulation of UCP1 expression and brown fat thermogenesis, suppression of UCP1 expression and enhanced diet-induced obesity were not observed until the b1-, b2-and b3 adrenergic receptors were inactivated, leading to complete suppression of b-adrenergic signaling to iBAT. 33 The synergy of factors associated with Ucp1 suggests a caveat as studies on gene expression related to BAT thermogenesis in humans are conducted. It is important to keep in mind that, as the complete absence of UCP1 has no effect on adiposity between 23 and 28 1C, inductions of two-to fivefold may not be biologically important, but would rather reflect an inherent lack of precision in mechanisms of gene expression, or to put it more positively, tolerance for the environment. The synergy among transcription factors for induction of Ucp1 is also accompanied by redundancy, which may mean that alternative strategies could be developed when searching for drugs to activate Ucp1/BAT induction.
Too much UCP1 is cytotoxic
A mouse hemizygous for a transgene in which Ucp1 is driven by the aP2 promoter is resistant to both genetic and diet-induced obesity. 34 Expression of the transgene occurs in both interscapular brown fat and white fat depots; however, the level of expression in white fat is only 2% of that expressed in interscapular brown fat. Interpretation of the expression of the aP2-Ucp1 transgene in iBAT is not straightforward, because both the endogenous Ucp1 and transgene contribute. Western blot analysis of UCP1 shows similar levels in wild-type and transgenic mice and primer extension analysis shows that both the transgene and endogenous gene contribute; however, the transgene is expressed constitutively, as expected for the properties of the aP2 promoter, whereas the endogenous gene is variably expressed in proportion to the requirements for thermogenesis; at low requirements, very little is derived from the endogenous gene but more as the brown adipocyte is stimulated adrenergically when the ambient temperature is reduced. The resistance to obesity in aP2-Ucp1 transgenic mice is probably determined by constant high levels of Ucp1 production from the constitutive expression of the aP2 promoter. The amount of brown fat in tg/ þ mice is B70% of that of wild-type mice, as estimated from wet weight, protein and DNA. 35 When mice that were homozygous for aP2-Ucp1 were generated, the amount of brown fat was reduced to about 15% of wild type, rendering the mice very resistant to dietinduced obesity and cold sensitivity in a manner indistinguishable from Ucp1À/À gene knockout mice. 35 Accordingly, increasing by a factor of 2, the level of aP2-derived UCP1 was sufficient to uncouple brown fat mitochondria to the point that the cells died. It is important to emphasize that an 85% loss of brown adipocytes in homozygous aP2-Ucp1 tg mice did not increase obesity, nor food intake, compared with the increase in food intake and obesity in Ucp1-DTA mice having only a 50% reduction in UCP1/BAT.
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Conclusions UCP1-based thermogenesis in brown adipose tissue in several experimental mammalian organisms has been shown to be a powerful thermogenic system for oxidation of excess fat to reduce obesity. A key feature of this system is that it can be induced simply by reducing ambient temperature. The induction associated with reduced adiposity is mainly observed to involve the conversion of white adipocytes to brown adipocytes. Although genetic studies in mice indicate that differences in Ucp1 induction among inbred mice involve several genes, the studies also show a high degree of synergy and redundancy for transcription and signaling pathways involved in the process. This redundancy promises that efforts to develop drugs to induce brown adipocytes in humans may have several pathways to be followed. An important aim of brown adipose tissue studies in humans is to determine whether, similar to the mouse, both a stable discrete brown fat tissue and a diffuse inducible population of brown adipocytes derived from a separate developmental lineage exist. If humans are similar to mice, then the expectation would be that the induction of brown fat thermogenesis will also be a highly variable trait.
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